DUBLIN--(BUSINESS WIRE)--The "Virus Filtration Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global virus filtration market reached a value of US$ 3.6 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 6.7 Billion by 2027, exhibiting at a CAGR of 11.2% during 2022-2027.
Companies Mentioned
- Asahi Kasei Medical Co. Ltd.
- Charles River Laboratories Inc.
- Clean Cells
- Danaher Corporation
- Merck KGaA
- Sartorius AG
- Thermo Fisher Scientific Inc.
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Virus filtration is an effective, non-destructive, and easy to use method of retaining both enveloped and non-enveloped virus particles on the surface or within the pores of a polymeric membrane. It finds extensive applications in continuous bioprocessing, which is gaining traction in monoclonal antibodies (MAbs) for providing small facility footprints.
As it does not impact the product quality, it is considered an ideal solution for manufacturing biological products, such as vaccines, somatic cells, gene therapy, and recombinant therapeutic proteins, and enhancing their safety. It is also used to remove blood-borne pathogens from plasma-derived products.
The urgent need for potential therapies and vaccines to treat coronavirus disease (COVID-19) patients under critical conditions is promoting the application of virus filtration in the convalescent plasma for reducing inflammatory mediators. Moreover, advancements in bioprocessing technologies, including single-use equipment, perfusion reactors, and chromatography resins, are positively influencing the adoption of virus filtration in the manufacturing of various biotherapeutic products.
The increasing demand for these products can be associated with the significant rise in the prevalence of chronic diseases worldwide.
Additionally, regulatory agencies of numerous countries have mandated virus control at various stages of the drug manufacturing process to ensure the virological safety of biological therapeutics, which is also contributing to the market growth. Apart from this, the introduction of an advanced asymmetric membrane structure that provides no impact on virus retention through pressure variations, high loads, or process interruptions is anticipated to stimulate the market growth.
Key Questions Answered in This Report:
- How has the global virus filtration market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global virus filtration market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global virus filtration market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Virus Filtration Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
7 Market Breakup by Application
8 Market Breakup by End Use
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
For more information about this report visit https://www.researchandmarkets.com/r/i3pghs
